Letter format
A landmark discovery in the genetics of for Parkinson's disease (PD) was the determination that mutations in the gene encoding glucocerebrosidase (GBA) convey risk for PD and dementia with Lewy bodies 1, 2 . Mutations in GBA are also causing the autosomal recessive disorder Gaucher's disease (GD). GD is a lysosomal storage disorder which present with a variety of features, including parkinsonism. While it has been clear that some GD-causing GBA mutations such as p.N409S are risk factors for PD, there has been some controversy regarding GBA mutations that do not cause GD and the risk for PD. Resolving this issue and the effect of such mutations on e.g. glucocerebrosidase activity, will have important implications for our understanding of the pathobiology of PD.
We present here a large genetic assessment of GBA using NeuroX genotyping of 6,249 PD cases and 6,032 controls 3 . In total, we detected 11 GBA coding variants. No large deletions or duplications at the GBA locus were identified. As expected p.N409S and p.E365K were enriched in cases compared to controls (Table1). Unfortunately, another relatively common disease associated L483P could not be genotyped 1 . Interestingly, variant p.T408M, reported as uncertain pathological significance, was also significantly overrepresented in cases. In total the majority of identified GBA variants were more common in cases compared to controls, the exception being p.K13R which is also reported as benign (Table1). Although some individuals were carrying multiple GBA mutations no high LD patterns were identified between coding variants (Supplementary Results).
In previous PD genome-wide association studies (GWAS), a locus approximately 150kb from GBA was implicated as a risk factor for PD (nominated as SYT11-GBA) 4 . Analysis of the noncoding variant rs71628662 previously implicated revealed a strong association for disease (Table1). Previous analyses suggested that this was independent of known GD causing mutations and the mechanism of action at this locus was therefore unclear. Conditioned analysis of rs71628662 on each of the identified coding variants revealed that the association at p.E365K completely accounted for the previously identified GWAS signal (conditional p.E365K rs71628662, p=0.6234). Within the current dataset the linkage disequilibrium between p.E365K and rs7168662 is very high (D'=0.987, r 2 =0.84).
Previously, another non-coding variant (rs114138760) was also identified as independent signal 5 . In the NeuroX dataset, this variant also showed association with disease (p=0.0001853) and remained significant following adjustment for the primary GWAS variant (p=0.0001511). Additionally, this signal also remained significant following adjustment for p.E365K, p.N409S, and p.T408M (p>0.007146) and of the 15 rs114138760 risk variant carriers, none carry p.L483P
In summary, this work affirms that functional alleles within GBA (p.E365K and p.T408M) that are insufficient to cause GD variants are robustly associated with PD. Further we show that a previously reported GWAS signal at this locus can be largely explained by protein coding variability within GBA. These data are consistent with p.E365K being the functional effector allele underlying the original GWA locus (GBA-SYT11 locus), as suggested previously 6 . The results from this current study suggest that efforts directed at replacing or augmenting glucocerebrosidase activity already underway for PD may have a wider ranging applicability than just for individuals with GD associated mutations in glucocerebrosidase. 
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